Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced, Metastatic Breast Cancer
Interventions: DRUG: LEE011|DRUG: Letrozole|DRUG: LEE011 Placebo
Sponsor: Novartis Pharmaceuticals